Benzinga | Jul 24, 2020 10:14AM EDT

Canaccord Genuity Maintains Hold on LeMaitre Vascular, Raises Price Target to $30

Canaccord Genuity maintains LeMaitre Vascular (NASDAQ:LMAT) with a Hold and raises the price target from $28 to $30.